NUVL — Nuvalent Income Statement
0.000.00%
- $5.26bn
- $4.14bn
- 32
- 25
- 62
- 33
Annual income statement for Nuvalent, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 16.9 | 45.8 | 86.1 | 149 | 280 |
Operating Profit | -16.9 | -45.8 | -86.1 | -149 | -280 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14.6 | -46.3 | -81.9 | -126 | -260 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.6 | -46.3 | -81.9 | -126 | -261 |
Net Income Before Extraordinary Items | |||||
Net Income | -14.6 | -46.3 | -81.9 | -126 | -261 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.6 | -46.3 | -81.9 | -126 | -261 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.311 | -0.959 | -1.65 | -2.17 | -3.93 |